C12N 2501/845
Gamma amino butyric acid [gaba]
Official title: Gamma amino butyric acid [GABA]
C12N2501/845 (Gamma amino butyric acid [gaba]) appears on 19 US grants and 35 published applications in this corpus.
Search patents in C12N- Granted patents
- 19
- Published applications
- 35
- Assignees
- 27
- Inventors
- 53
- Latest grant
- 30 Jan 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 1 | 1 |
| 2008 | 2 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 2 |
| 2011 | 0 | 0 |
| 2012 | 1 | 6 |
| 2013 | 1 | 2 |
| 2014 | 1 | 1 |
| 2015 | 0 | 3 |
| 2016 | 2 | 2 |
| 2017 | 5 | 4 |
| 2018 | 0 | 0 |
| 2019 | 2 | 2 |
| 2020 | 1 | 0 |
| 2021 | 0 | 3 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
| 2025 | 0 | 2 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method of preparing hematopoietic stem and progenitor cells for transplantation30 Jan 2024US 11,883,436 B2The Board of Trustees of the University of Illinois
- Generation of functional beta cells from human pluripotent stem cell-derived endocrine progenitors15 Mar 2022US 11,274,280 B2Novo Nordisk A/S
- Alpha-cell re-generation combined with conversion to beta cells7 Apr 2020US 10,610,504 B2Centre National De La Recherche Scientifique
- Methods for making definitive endoderm using at least GDF-816 Jul 2019US 10,351,820 B2Janssen Biotech, Inc.
- Differentiation of pluripotent stem cells19 Mar 2019US 10,233,421 B2Janssen Biotech, Inc.
- Gene correction induced neural stem cells using huntingtin gene-specific guide rna, and cell therapeutic agent using the same30 Apr 2026US 2026/0115318 A1Korea University Research and Business Foundation
- Engineered immune cell platform10 Jul 2025US 2025/0222028 A1Cancer Research Technology Limited
- Method for differentiating hematopoietic stem/progenitor cells into nk cells22 May 2025US 2025/0163379 A1Hemacell Biotechnology Inc.
- Ipsc-derived immune cells in prophylaxis and treatment of age-associated and neurodegenerative diseases31 Oct 2024US 2024/0358751 A1Cedars-Sinai Medical Center
- Method of Preparing Hematopoietic Stem and Progenitor Cells for Transplantation17 Feb 2022US 2022/0047639 A1The Board of Trustees of the University of Illinois
Most cited
By later US patents
- Culturing human embryonic stem cells in medium containing pipecholic acid and gamma amino butyric acid139US 7,442,548 B2Wisconsin Alumni Research Foundation · 2008
- Medium containing pipecholic acid and gamma amino butyric acid and culture of embryonic stem cells138US 7,449,334 B2Wisconsin Alumni Research Foundation · 2008
- Methods for differentiating neural stem cells to neurons or smooth muscle cells using TGT-.beta. super family growth factors78US 6,001,654 ACalifornia Institute of Technology · 1999
- Small molecules supporting pluripotent cell growth and methods thereof38US 8,685,726 B2ViaCyte, Inc. · 2014
- Inducing sterility in fish by disrupting the development of the GnRH system6US 7,194,978 B2Ramot at Tel-Aviv University Ltd. · 2007